Strength
50; 25 mg/1; mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702024213
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
DOLUTEGRAVIR SODIUM; RILPIVIRINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA210192On Market Since
11/21/2017
Pharmacological Classes
HIV Integrase Inhibitors
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Multidrug and Toxin Extrusion Transporter 1 Inhibitors
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
Organic Cation Transporter 2 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
LAMICTAL 25 MG TABLET
Brand
00173063302•GlaxoSmithKline LLC
$10.2773
per EA
LAMICTAL 100 MG TABLET
Brand
00173064255•GlaxoSmithKline LLC
$10.9197
per EA
INTELENCE 100 MG TABLET
Brand
59676057001•Janssen Products LP
$10.9213
per EA
LAMICTAL 25 MG DISPER TABLET
Brand
00173052700•GlaxoSmithKline LLC
$11.2131
per EA
LAMICTAL 150 MG TABLET
Brand
00173064360•GlaxoSmithKline LLC
$11.4710
per EA
LAMICTAL 200 MG TABLET
Brand
00173064460•GlaxoSmithKline LLC
$12.0609
per EA
LAMICTAL ODT 25 MG TABLET
Brand
00173077202•GlaxoSmithKline LLC
$12.8016
per EA
LAMICTAL ODT 50 MG TABLET
Brand
00173077402•GlaxoSmithKline LLC
$13.6529
per EA
LAMICTAL XR 25 MG TABLET
Brand
00173075400•GlaxoSmithKline LLC
$14.1547
per EA
LAMICTAL ODT 100 MG TABLET
Brand
00173077602•GlaxoSmithKline LLC
$14.6263
per EA